SEC Form 4 · accession 0001209191-19-012593
SPECTRUM PHARMACEUTICALS INC · SPPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony E Maida III
Director
Period of report
Feb 21, 2019
Accepted (ET)
Feb 22, 2019 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000831547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Feb 21, 2019 | M | 5,500 | $5.05 | A | 38,488 | D | |
| Common Stock, $0.001 par value | Feb 21, 2019 | S | 5,500 | $11.63 | D | 32,988 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option Exercise (Right to Buy) | $5.05 | Feb 21, 2019 | M | 5,500 | D | Jun 18, 2010 | Apr 20, 2020 | Common Stock | 5,500 | 18,800 | D |
Explanation of responses
- F1All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018.